Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P960009/S547

Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (DBS Neurostimulator Implantable B35200)

Medtronic, Inc. · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONP960009/S547

What did the FDA decide?

The FDA recorded decision OK30 on 2026-10-29 for PMA supplement P960009/S547, a 30-Day Notice submitted by Medtronic, Inc. under the supplement reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The supplement concerns the Activa Deep Brain Stimulation Therapy System, specifically the Percept PC BrainSense DBS Neurostimulator Implantable B35200, a device in the implanted electrical stimulator category for parkinsonian tremor (product code MHY, Neurology). The action covers the listed manufacturing process changes rather than a new approval of the whole system.

The recorded statement lists six changes: enhanced operator verification of the FactoryWorks processing step and recorded battery pre-weight; pre-weight and post-weight out-of-control action plans added to Process Operation Descriptions; software and Human Machine Interface updates that automatically reject batteries with fill weights above the established final-fill reasonable limit; dedicated white work-in-progress trays for electrolyte-filled batteries; an isopropyl alcohol wipe to remove residual electrolyte before subsequent processing; and removal of Ball Press and Button Press certification prerequisites from the ram-change procedure for Medium Rate Line 2 operators, with supervisors and engineers retaining certification responsibility. No supporting documents were included, so the basis for OK30 and any clinical implications remain unknown.

FDA approval order statement

1. Enhanced operator verification of the applicable FactoryWorks processing step and recorded battery pre-weight.2. Addition of pre-weight and post-weight out-of-control action plans to the applicable Process Operation Descriptions.3. Software and Human Machine Interface updates that will automatically reject batteries with fill weights above the established final-fill reasonable limit.4. Introduction of dedicated white work-in-progress trays to distinguish electrolyte-filled batteries and improve line clearance, handling, and traceability.5. Use of an isopropyl alcohol wipe to remove residual electrolyte from battery surfaces before subsequent processing.6. Removal of the Ball Press and Button Press certification prerequisites from the Ball and Button Press Ram Change procedure, allowing Medium Rate Line 2 operators to qualify for press ram changes by completing only the ram-change procedure while supervisors and engineers retain responsibility for operator certification
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Oct 29, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P960009/S547
Regulatory pathway
PMA supplement
Product code
MHY
Decision code
OK30
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.

Product code
MHY
FDA device class
3

For the original device and its historical approval scope, see PMA P960009. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P960009 · Original PMA

    MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM

  2. P960009/S546 · Related supplement

    MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM

  3. P960009/S547 received

    Application receipt date recorded by FDA.

  4. P960009/S542 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense

  5. P960009/S547 · FDA decision

    30-Day Notice

  6. P960009/S548 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense

  7. P960009/S545 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (B32000)

Timeline entries are records held by MedtechLedger for P960009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P960009

Explore the linked device profile

Other records with product code MHY

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 28, 2026FDA
ABBOTT MEDICALPMA supplementOct 27, 2026FDA
Infinity DBS IPGP140009/S139
ABBOTT MEDICALPMA supplementSep 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records